Alfa-Glicerilfosforilcolina numita si Colina-Alfoscerat
Alfa-Glicerilfosforilcolina un precursor de acetilcolina un neurotransmitator important
1 Alfa-GPC (Alfa-Glicerilfosforilcolina) un precursor direct de Acetilcolina, cu mai multa satisfactie in activitate si eficacitate mai ridicata decit versus Citicolina (CDP Colina).
2 Nivelul plasmatic de Colina mai ridicat la Alfa-GPC (Alfa-Glicerilfosforilcolina) fata de Citicolina (CDP Colina).
Alfa-Glicerilfosforilcolina Colina-Alfoscerat
Alfa-Glicerilfosforilcolina
numita si Colina-Alfoscerat
Alfa-GPC un precursor de acetilcolina un neurotransmitator important
Colina-Alfoscerat doua in unul, sub influenta enzimelor se scindeaza in:
Colina care este utilizata pentru sinteza acetilcolinei
iar,
1 Alfa-GPC (Alfa-Glicerilfosforilcolina) un precursor direct de Acetilcolina,
cu mai multa satisfactie in activitate si eficacitate mai ridicata
decit
versus Citicolina (CDP Colina)
- The results suggest that in most tests alpha-GPC possessed
a statistical higher efficacy and an overall more satisfactory activity
assessed by both patients and investigators compared with CDP.
9. Alfa-GPC (Alfa-Glicerilfosforilcolina) in interactiune cu sistemul colinergic-dopaminergic
un medicament colinomimetic, are actiune asemanatoare cu a acetilcolinei.
10. Alfa-GPC (Alfa-Glicerilfosforilcolina) prin sistemul noradrenergic moduleaza
GABA endogen cortical
11. Alfa-GPC (Alfa-Glicerilfosforilcolina) cu actiune nootropica
in terapia cerebrala
12. Alfa-GPC (Alfa-Glicerilfosforilcolina) cu efect si influenta la mecanismul
cognitiv
13. Farmacocinetica la Alfa-GPC (Alfa-Glicerilfosforilcolina) cu absorbtia,
distributia si excretie
14. Alfa-GPC (Alfa-Glicerilfosforilcolina) cu efect de crestere cognitiva, parametri
biochimici la tineri si varstnici
15. Alfa-GPC (Alfa-Glicerilfosforilcolina) cu efect la receptorii muscarinici
16. Colina-Alfoscerat prin tratament influenteaza receptorii muscarinici colinergici
in hipocampus
17. Alfa-GPC (Alfa-Glicerilfosforilcolina) la declinul cognitiv si bolile cerebrovasculare,
o analiza clinica
18. Alfa-GPC (Alfa-Glicerilfosforilcolina) in refacerea mentala dupa atacul ischemic
cerebral - accidentul vascular cerebral, studiu multicentru
19. Colina-Alfoscerat in tratamentul de schimbarea microanatomice in cerebral
20. Colina-Alfoscerat pe cale orala in tratamentul de a contracara schimbarea
anatomica in hipocampus
21. Colina-Alfoscerat cu efect in tratamentul receptorului factorului de crestere
neuronala (NGF-nerve growth
factor) in cortexul cerebral
Acetil L-Carnitina Arginat stimuleaza cresterea neuritiilor cu 19,5% pierduti pe masura imbatriniri, prin
Factorul de crestere neuronala (NGF-nerve growth factor)
22. Alfa-GPC (Alfa-Glicerilfosforilcolina) prin tratament cu influenta in neurotransmisia
colinergica
23. Alfa-GPC (Alfa-Glicerilfosforilcolina) promoveaza cresterea
activitatii de Protein-Kinaza C, cea ce explica efectul sau in cortexul
cerebral
24. Alfa-GPC (Alfa-Glicerilfosforilcolina) in tratamentul de colin-acetil-transferaza
si acetilcolinesteraza in hipocampus
26. Alfa-GPC (Alfa-Glicerilfosforilcolina) versus ST-200 - Sigma-Tau SpA - Acetil
L-Carnitina
la pacienti cu dementa senila la Alzheimer
27. Alfa-GPC (Alfa-Glicerilfosforilcolina) in tratamentul pentru
dementa vasculara, moduleaza sistemul transmitator colinergic
Bibliografie - Referinte la Alfa-GPC
(Alfa-Glicerilfosforilcolina)
Informatii din bibliografia electronica la tema: Nutritie si sanatate
1. Di Perri R, Coppola G, Ambrosio LA, Grasso A, Puca FM, Rizzo M. A multicentre
trial to evaluate the efficacy and tolerability of alpha-glycerylphosphorylcholine
versus cytosine diphosphocholine in patients with vascular dementia.
First Neurological Clinic, University of Messina, Italy. J Int Med
Res. 1991 Jul-Aug;19(4):330-41.
2.
Gatti G, Barzaghi N, Acuto G, Abbiati G, Fossati T, Perucca E. A comparative
study of free plasma choline levels following intramuscular administration
of L-alpha-glycerylphosphorylcholine and citicoline in normal volunteers.
Department of Internal Medicine and Therapeutics, University of Pavia,
Italy. Int J Clin Pharmacol Ther Toxicol. 1992 Sep;30(9):331-5.
3. Paciaroni E, Tomassini PF. Controlled clinical trial of the efficacy
and safety of choline alphoscerate (alpha-GPC) versus oxiracetam in patients
with mild
cognitive deficit of vascular origin. Giornal Italiano di Ricerche
Cliniche e Terepeutiche.
1993;14(2):29-34.
4. Aleppo G, et al. Chronic l-alpha-glycerylphosphoryl-choline increases inositol
phosphate formation in brain slices and neuronal cultures. Pharmacol
Toxicol 1994 Feb;74(2):95-100.
5. Sigala S, Imperato A, Rizzonelli P,
et al. L-alpha-glycerylphosphorylcholine antagonizes scopolamine-induced amnesia
and enhances hippocampal
cholinergic transmission in the rat. Eur J Pharmacol. Feb1992;211(3):351-8.
6. Lopez CM, Govoni S, Battaini F, Bergamaschi S, Longoni A, Giaroni
C, Trabucchi M. Effect of a new cognition enhancer, alpha-glycerylphosphorylcholine,
on scopolamine-induced
amnesia and brain acetylcholine. Institute of Pharmacological Sciences, University
of Milan, Italy. Pharmacol Biochem Behav. 1991 Aug;39(4):835-40.
7. Canal N, Franceschi M, Alberoni M, et al. Effect of L-alpha-glyceryl-phosphorylcholine
on amnesia caused by scopolamine. Int J Clin Pharmacol Ther Toxicol. Mar1991;29(3):103-7.
8. De Jesus Moreno Moreno M. Cognitive improvement in mild to moderate Alzheimer's
dementia after treatment with the
acetylcholine precursor
choline alfoscerate:
a multicenter, double-blind, randomized, placebo-controlled
trial.
Instituto Nacional de la Senectud, Mexico City, Mexico. Clin
Ther. 2003 Jan;25(1):178-93
9. Trabucchi M, Govoni S, Battaini F. Changes
in the interaction between CNS cholinergic and dopaminergic neurons induced
by L-alpha-glycerylphosphorylcholine,
a cholinomimetic
drug. Farmaco [Sci]. 1986 Apr;41(4):325-34.
10. Ferraro L, Tanganelli S, Marani L, Bianchi C, Beani L, Siniscalchi
A. Evidence for an in vivo and in vitro modulation of endogenous
cortical GABA
release by alpha-glycerylphosphorylcholine. Institute of Pharmacology,
University of Ferrara,
Italy. Neurochem Res. 1996 May;21(5):547-52.
11. Abbati C, et al. Nootropic
therapy of cerebral aging. Advances in Therapy. 1991;8(6):268-276.
12. Drago F, Mauceri F, Nardo L, Valerio C, Lauria N, Rampello L, Guidi
G. Behavioral effects of L-alpha-glycerylphosphorylcholine:
influence on cognitive
mechanisms in the rat. Institute of Pharmacology, University
of Catania Medical School, Italy. Pharmacol Biochem Behav. 1992 Feb;41(2):445-8.
13. Abbiati G, Fossati T, Lachmann G, Bergamaschi M, Castiglioni C.
Absorption, tissue distribution and excretion of radiolabelled
compounds in rats after administration
of [14C]-L-alpha-glycerylphosphorylcholine. LPB Research Institute,
Cinisello B., Milan, Italy. Eur J Drug Metab Pharmacokinet. 1993
Apr-Jun;18(2):173-80.
14. Schettini G, Ventra C, Florio T, Grimaldi M, Meucci O, Scorziello
A, Postiglione A, Marino A. Molecular mechanisms mediating the
effects of L-alpha-glycerylphosphorylcholine,
a new cognition-enhancing drug, on behavioral and biochemical
parameters in young and aged rats. Department of Human Communicative
Science, II School of Medicine, Naples, Italy. Pharmacol Biochem
Behav. 1992
Sep;43(1):139-51.
15. Muccioli G, Raso GM, Ghé C, Di Carlo R. Effect of
L-alpha glycerylphosphorylcholine on muscarinic receptors
and membrane
microviscosity of aged rat
brain. Institute of Pharmacology and Experimental Therapy,
University of
Turin, Torino, Italy. Prog Neuropsychopharmacol Biol Psychiatry.
1996 Feb;20(2):323-39.
16. Amenta F, Liu A, Zeng YC, Zaccheo D. Muscarinic cholinergic
receptors in the hippocampus of aged rats: influence of choline alphoscerate
treatment. Sezione di Anatomia Umana, Istituto di Farmacologia, Università
di Camerino, Italy. Mech Ageing Dev. 1994 Oct 1;76(1):49-64.
17.
Parnetti L, Amenta F, Gallai V. Choline alphoscerate in cognitive
decline and
in acute cerebrovascular disease:
an analysis of published clinical data. Department of Neuroscience,
University of Perugia, Via E Dal Pozzo, 06126, Perugia,
Italy. Mech Ageing Dev.
2001 Nov;122(16):2041-55.
18.
Barbagallo Sangiorgi G, Barbagallo M, Giordano M, Meli
M, Panzarasa R. alpha-Glycerophosphocholine in the mental
recovery
of cerebral ischemic
attacks. An Italian multicenter
clinical trial. Institute of Internal Medicine and
Geriatrics, University of Palermo, Italy. Ann N Y Acad
Sci. 1994 Jun 30;717:253-69.
19. Amenta F, Ferrante F, Vega JA, Zaccheo D. Long term
choline alfoscerate treatment counters age-dependent
microanatomical changes in rat
brain. Sezione di Anatomia
Umana, Università di Camerino, Italy. Prog Neuropsychopharmacol
Biol Psychiatry. 1994 Sep;18(5):915-24.
20. Ricci A, Bronzetti E, Vega JA, Amenta F. Oral
choline alfoscerate counteracts age-dependent loss of mossy fibres
in the rat hippocampus. Dipartimento di Scienze Cardiovascolari
e Respiratorie, University La Sapienza, Rome, Italy. Mech Ageing
Dev. 1992;66(1):81-91.
21. Vega JA, Cavallotti C, del Valle ME, Mancini M, Amenta F.
Nerve growth factor receptor immunoreactivity in the cerebellar
cortex of aged rats: effect of choline
alfoscerate treatment. Sezione di Anatomia Umana, Istituto di Farmacologia,
Universita di Camerino, Italy. Mech Ageing Dev. 1993 Jun;69(1-2):119-27.
22. Amenta F, Franch F, Ricci A, Vega JA. Cholinergic neurotransmission in
the hippocampus of aged rats: influence of L-alpha-glycerylphosphorylcholine
treatment.
Sezione di Anatomia Umana, Istituto di Farmacologia, Università di Camerino,
Italy. Ann
N Y Acad Sci. 1993 Sep 24;695:311-3.
23. Govoni S, Battaini F, Lucchi L, Pascale A, Trabucchi M. Protein kinase
C (PKC) translocation in rat brain cortex is promoted in vivo and in vitro
by alpha-glycerylphosphorylcholine,
a cognition-enhancing drug. Institute of Pharmacological Sciences, University
of Milan, Italy. Ann N Y Acad Sci. 1993 Sep 24;695:307-10.
24. Amenta
F, Bronzetti E, Mancini M, Vega JA, Zaccheo D. Choline acetyltransferase and
acetylcholinesterase in the hippocampus
of aged rats: sensitivity
to choline alphoscerate treatment. Sezione di Anatomia
Umana, Istituto di Farmacologia,
Università di Camerino, Italy. Mech Ageing Dev. 1994 May;74(1-2):47-58.
25. Parnetti L, Abate G, Bartorelli L, Cucinotta D, Cuzzupoli
M, Maggioni M, Villardita C, Senin U. Multicentre study
of l-alpha-glyceryl-phosphorylcholine vs ST200
among patients with probable senile dementia of Alzheimer's
type. Drugs Aging 1993 Mar-Apr;3(2):159-64.
26. Parnetti L, Abate G, Bartorelli L, Cucinotta D, Cuzzupoli M,
Maggioni M, Villardita C, Senin U. Multicentre study of l-alpha-glyceryl-phosphorylcholine
vs ST200
among patients with probable senile dementia of Alzheimer's type.
Institute
of Gerontology and Geriatrics, University of Perugia, Italy. Drugs
Aging. 1993 Mar-Apr;3(2):159-64.
27. Amenta F, Di Tullio MA, Tomassoni
D. The cholinergic approach for the treatment of vascular
dementia: evidence from pre-clinical and clinical studies.
Clinical Research Unit, Department of Pharmacological Sciences
and Experimental
Medicine, University of Camerino, 62032 Camerino, Italy.
Clin
Exp Hypertens. 2002 Oct-Nov;24(7-8):697-713.
Parerea din pasajele acestui site nu a fost independent cercetate sau confirmate.
Alfa-GPC (Alfa-Glicerilfosforilcolina) un precursor direct de Acetilcolina, cu mai multa satisfactie in activitate si eficacitate mai ridicata decit versus Citicolina (CDP Colina).
Colina-Alfoscerat doua in unul, sub influenta enzimelor se scindeaza in:
Alfa-GPC (Alfa-Glicerilfosforilcolina) un precursor direct de Acetilcolina,
cu mai multa satisfactie in activitate si eficacitate mai ridicata
decit
versus Citicolina (CDP Colina)
